102 related articles for article (PubMed ID: 25148110)
61. Association analysis of the catechol-O-methyltransferase /methylenetetrahydrofolate reductase genes and cognition in late-onset depression.
Wang X; Wang Z; Wu Y; Yuan Y; Hou Z; Hou G
Psychiatry Clin Neurosci; 2014 May; 68(5):344-52. PubMed ID: 24373005
[TBL] [Abstract][Full Text] [Related]
62. Effects of COMT, DRD2, BDNF, and APOE Genotypic Variation on Treatment Efficacy and Cognitive Side Effects of Electroconvulsive Therapy.
Bousman CA; Katalinic N; Martin DM; Smith DJ; Ingram A; Dowling N; Ng C; Loo CK
J ECT; 2015 Jun; 31(2):129-35. PubMed ID: 25148110
[TBL] [Abstract][Full Text] [Related]
63. Genetic mechanisms of electroconvulsive therapy response in depression.
Benson-Martin JJ; Stein DJ; Baldwin DS; Domschke K
Hum Psychopharmacol; 2016 May; 31(3):247-51. PubMed ID: 27062668
[TBL] [Abstract][Full Text] [Related]
64. Neurocognitive effects after brief pulse and ultrabrief pulse unilateral electroconvulsive therapy for major depression: a review.
Verwijk E; Comijs HC; Kok RM; Spaans HP; Stek ML; Scherder EJ
J Affect Disord; 2012 Nov; 140(3):233-43. PubMed ID: 22595374
[TBL] [Abstract][Full Text] [Related]
65. Specific and common genes implicated across major mental disorders: a review of meta-analysis studies.
Gatt JM; Burton KL; Williams LM; Schofield PR
J Psychiatr Res; 2015 Jan; 60():1-13. PubMed ID: 25287955
[TBL] [Abstract][Full Text] [Related]
66. Clinical and biological predictors of response to electroconvulsive therapy (ECT): a review.
Pinna M; Manchia M; Oppo R; Scano F; Pillai G; Loche AP; Salis P; Minnai GP
Neurosci Lett; 2018 Mar; 669():32-42. PubMed ID: 27793702
[TBL] [Abstract][Full Text] [Related]
67. A Systematic Review and Meta-Analysis of Brief Versus Ultrabrief Right Unilateral Electroconvulsive Therapy for Depression.
Tor PC; Bautovich A; Wang MJ; Martin D; Harvey SB; Loo C
J Clin Psychiatry; 2015 Sep; 76(9):e1092-8. PubMed ID: 26213985
[TBL] [Abstract][Full Text] [Related]
68. Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis.
Semkovska M; McLoughlin DM
Biol Psychiatry; 2010 Sep; 68(6):568-77. PubMed ID: 20673880
[TBL] [Abstract][Full Text] [Related]
69. [Cognitive deficits associated with electroconvulsive therapy for depression: moderating factors and neuropsychological tests].
Margittai Z; Yardimci T; Marin D; Kamp D; Cordes J; Kujovic M
Fortschr Neurol Psychiatr; 2018 Nov; 86(11):690-698. PubMed ID: 30654401
[TBL] [Abstract][Full Text] [Related]
70. Systematic Review of Genetic Risk Factors for Sustaining a Mild Traumatic Brain Injury.
Panenka WJ; Gardner AJ; Dretsch MN; Crynen GC; Crawford FC; Iverson GL
J Neurotrauma; 2017 Jul; 34(13):2093-2099. PubMed ID: 28100103
[TBL] [Abstract][Full Text] [Related]
71. Increased BDNF levels after electroconvulsive therapy in patients with major depressive disorder: A meta-analysis study.
Rocha RB; Dondossola ER; Grande AJ; Colonetti T; Ceretta LB; Passos IC; Quevedo J; da Rosa MI
J Psychiatr Res; 2016 Dec; 83():47-53. PubMed ID: 27552533
[TBL] [Abstract][Full Text] [Related]
72. The electroconvulsive therapy controversy: evidence and ethics.
Reisner AD
Neuropsychol Rev; 2003 Dec; 13(4):199-219. PubMed ID: 15000226
[TBL] [Abstract][Full Text] [Related]
73. [Electroconvulsive therapy for the treatment of major depression].
Zilles D; Wolff-Menzler C; Wiltfang J
Nervenarzt; 2015 May; 86(5):549-56. PubMed ID: 25269533
[TBL] [Abstract][Full Text] [Related]
74. Genetics and functional imaging: effects of APOE, BDNF, COMT, and KIBRA in aging.
Papenberg G; Salami A; Persson J; Lindenberger U; Bäckman L
Neuropsychol Rev; 2015 Mar; 25(1):47-62. PubMed ID: 25666727
[TBL] [Abstract][Full Text] [Related]
75. Key updates in the clinical application of electroconvulsive therapy.
Weiner RD; Reti IM
Int Rev Psychiatry; 2017 Apr; 29(2):54-62. PubMed ID: 28406327
[TBL] [Abstract][Full Text] [Related]
76. [Cognitive side effects of electroconvulsive therapy].
Petersen JZ; Miskowiak KW
Ugeskr Laeger; 2018 Apr; 180(18):. PubMed ID: 29720345
[TBL] [Abstract][Full Text] [Related]
77. ECT and memory loss.
Squire LR
Am J Psychiatry; 1977 Sep; 134(9):997-1001. PubMed ID: 331969
[TBL] [Abstract][Full Text] [Related]
78. Association between COMT gene Val108/158Met and antidepressive treatment response: A meta-analysis.
Tang Z; Zhang S; Guo D; Wang H
Gene; 2020 Apr; 734():144333. PubMed ID: 31972309
[TBL] [Abstract][Full Text] [Related]
79. Brain-derived neurotrophic factor Val66Met polymorphism association with antidepressant efficacy: a systematic review and meta-analysis.
Yan T; Wang L; Kuang W; Xu J; Li S; Chen J; Yang Y
Asia Pac Psychiatry; 2014 Sep; 6(3):241-51. PubMed ID: 25231750
[TBL] [Abstract][Full Text] [Related]
80. Acetylcholinesterase inhibitors for electroconvulsive therapy-induced cognitive side effects: a systematic review.
Henstra MJ; Jansma EP; van der Velde N; Swart EL; Stek ML; Rhebergen D
Int J Geriatr Psychiatry; 2017 May; 32(5):522-531. PubMed ID: 28295591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
